BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18154487)

  • 1. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment.
    Aboulafia DM; Puswella AL
    AIDS Patient Care STDS; 2007 Dec; 21(12):900-7. PubMed ID: 18154487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term remission of AIDS-related primary central nervous system lymphoma in a patient under antiretroviral therapy: a case report and review of the literature.
    Gijs PJ; Clerc O
    AIDS Res Ther; 2021 Oct; 18(1):76. PubMed ID: 34666791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery.
    Hoffmann C; Tabrizian S; Wolf E; Eggers C; Stoehr A; Plettenberg A; Buhk T; Stellbrink HJ; Horst HA; Jäger H; Rosenkranz T
    AIDS; 2001 Nov; 15(16):2119-27. PubMed ID: 11684931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy.
    Chotmongkol V; Pesee M
    J Med Assoc Thai; 2002 May; 85(5):634-7. PubMed ID: 12188396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
    Skiest DJ; Crosby C
    AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Active Antiretroviral Therapy and Gamma Knife Radiosurgery for the Treatment of AIDS-Related Primary Central Nervous System Lymphoma.
    Alvarez-Pinzon AM; Valerio JE; Swedberg HN; Elwasila SM; Wolf A; Alonso JR
    World Neurosurg; 2019 Apr; 124():310-312. PubMed ID: 30654158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.
    Marretta L; Stocker H; Drauz D; Mueller M; Masuhr A; Dieckmann S; Wong V; Koch A; Grueneisen A; Arastéh K; Weiss R
    Eur J Med Res; 2011 May; 16(5):197-205. PubMed ID: 21719392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of suspending HAART in selected patients with controlled HIV replication.
    Jacobs B; Neil N; Aboulafia DM
    AIDS Patient Care STDS; 2005 Jul; 19(7):429-38. PubMed ID: 16053400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
    Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
    Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019.
    Aboulafia DM; Ratner L; Miles SA; Harrington WJ;
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):399-402. PubMed ID: 16640817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.
    Mata RC; Viciana P; de Alarcón A; López-Cortés LF; Gómez-Vera J; Trastoy M; Cisneros JM
    AIDS Patient Care STDS; 2005 Sep; 19(9):550-62. PubMed ID: 16164382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.